V. E. Janson

627 total citations
30 papers, 494 citations indexed

About

V. E. Janson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, V. E. Janson has authored 30 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in V. E. Janson's work include Neuroscience and Neuropharmacology Research (5 papers), Metabolism and Genetic Disorders (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). V. E. Janson is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Metabolism and Genetic Disorders (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). V. E. Janson collaborates with scholars based in United States and Sweden. V. E. Janson's co-authors include B. V. Rama Sastry, Neelam Jaiswal, Jean-Louis Horn, Gurkeerat Singh, John Franks, Piotr K. Janicki, Stanley L. Barnwell, W. Trent Franks, Kjell Grankvist and Anders Johansson and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

V. E. Janson

30 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. E. Janson United States 14 222 185 66 64 57 30 494
Mark A. Osinski United States 16 273 1.2× 288 1.6× 36 0.5× 135 2.1× 51 0.9× 31 656
Gonzálo Emiliano Aranda-Abreu Mexico 14 269 1.2× 109 0.6× 39 0.6× 85 1.3× 36 0.6× 75 744
André Bachy France 9 338 1.5× 470 2.5× 79 1.2× 62 1.0× 122 2.1× 14 595
Wolfram Gaida Germany 15 519 2.3× 516 2.8× 49 0.7× 108 1.7× 42 0.7× 25 801
James H. Allison United States 10 333 1.5× 202 1.1× 43 0.7× 138 2.2× 58 1.0× 10 885
Jaroslav H. Boublik United States 15 370 1.7× 512 2.8× 128 1.9× 189 3.0× 52 0.9× 27 791
Yoshiko Yamamoto Japan 12 100 0.5× 113 0.6× 64 1.0× 20 0.3× 116 2.0× 49 420
Guoming Zhang China 9 175 0.8× 199 1.1× 12 0.2× 42 0.7× 74 1.3× 31 548
David R. Luthin United States 15 352 1.6× 140 0.8× 71 1.1× 136 2.1× 21 0.4× 26 703
Monika Schäfer Germany 10 282 1.3× 324 1.8× 45 0.7× 85 1.3× 72 1.3× 11 906

Countries citing papers authored by V. E. Janson

Since Specialization
Citations

This map shows the geographic impact of V. E. Janson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. E. Janson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. E. Janson more than expected).

Fields of papers citing papers by V. E. Janson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. E. Janson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. E. Janson. The network helps show where V. E. Janson may publish in the future.

Co-authorship network of co-authors of V. E. Janson

This figure shows the co-authorship network connecting the top 25 collaborators of V. E. Janson. A scholar is included among the top collaborators of V. E. Janson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. E. Janson. V. E. Janson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janson, V. E., Anders Johansson, & Kjell Grankvist. (2010). Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance. Cell Death and Disease. 1(9). e78–e78. 23 indexed citations
2.
Persson, Erik, et al.. (2008). Messenger RNA levels of estrogen receptors α and β and progesterone receptors in the cyclic and inseminated/early pregnant sow uterus. Animal Reproduction Science. 112(3-4). 215–228. 8 indexed citations
3.
Sastry, B. V. Rama, et al.. (1999). Influence of Halothane on Phospholipase A 2 and Enzymatic Methylations in the Rat Retinal Membranes†. Journal of Ocular Pharmacology and Therapeutics. 15(2). 165–178. 1 indexed citations
4.
Franks, John, Artur W. Wamil, Piotr K. Janicki, et al.. (1998). Anesthetic-induced Alteration of Ca2+Homeostasis in Neural Cells . Anesthesiology. 89(1). 149–164. 32 indexed citations
5.
Janson, V. E., et al.. (1997). Cholinergic markers in transformed trophoblast cells: BeWo and JAr cells.. PubMed. 43(4). 559–65. 5 indexed citations
6.
7.
Sastry, B. V. Rama, et al.. (1995). Evaluation of the Nature of Rat Retinal Acetylcholinesterase Using a Specific Substrate and a Specific Inhibitor. Journal of Ocular Pharmacology and Therapeutics. 11(3). 401–409. 3 indexed citations
8.
9.
Janicki, Piotr K., et al.. (1995). Inhibition of plasma membrane Ca2+-atpase pump activity in cultured c6 glioma cells by halothane and xenon. Life Sciences. 56(10). PL219–PL224. 13 indexed citations
10.
Sastry, B. V. Rama, et al.. (1994). S-Adenosyl-L-Methionine–Mediated Enzymatic Methylations in the Rat Retinal Membranes. Journal of Ocular Pharmacology and Therapeutics. 10(1). 253–263. 4 indexed citations
11.
Sastry, B. V. Rama & V. E. Janson. (1994). Retinal Cholinergic System: Characterization of Rat Retinal Acetyltransferases Using Specific Inhibitors of Choline- and Carnitine-Acetyltransferases. Journal of Ocular Pharmacology and Therapeutics. 10(1). 203–215. 6 indexed citations
12.
Sastry, B. V. Rama, S. Mouton, V. E. Janson, & J. R. Kambam. (1993). Tobacco Smoking by Pregnant Women Disturbances in Metabolism of Branched Chain Amino Acids and Fetal Growtha. Annals of the New York Academy of Sciences. 678(1). 361–363. 3 indexed citations
13.
Sastry, B. V. Rama, et al.. (1991). Significance of Substance P— and Enkephalin—Peptide Systems in the Male Genital Tracta. Annals of the New York Academy of Sciences. 632(1). 339–353. 18 indexed citations
14.
Sastry, B. V. Rama, et al.. (1988). Relationships between chemical structure and inhibition of choline acetyltransferase by 2-(α-naphthoyl)ethyltrimethylammonium and related compounds. Pharmacological Research Communications. 20(9). 751–771. 9 indexed citations
15.
Sastry, B. V. Rama, et al.. (1988). 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.. Journal of Pharmacology and Experimental Therapeutics. 245(1). 72–80. 19 indexed citations
16.
Sastry, B. V. Rama & V. E. Janson. (1987). Opioid‐Like Peptides in Human Semen and Their Effects on Sperm Motilitya. Annals of the New York Academy of Sciences. 513(1). 586–588. 1 indexed citations
17.
Janson, V. E., et al.. (1983). Changes in Enzymes of the Cholinergic System and Acetylcholine Release in the Cerebra of Aging Male Fischer Rats. Pharmacology. 26(2). 61–72. 61 indexed citations
18.
Janson, V. E., et al.. (1982). Enhancement of the responsiveness of the rat diaphragm by L-methionine and phospholipid methylation and their relationships to aging.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 629–636. 12 indexed citations
19.
Sastry, B. V. Rama, et al.. (1981). Inhibition of human sperm motility by inhibitors of choline acetyltransferase.. Journal of Pharmacology and Experimental Therapeutics. 216(2). 378–384. 39 indexed citations
20.
Sastry, B. V. Rama, et al.. (1981). Peptides from human placenta: methionine enkephalin and substance P.. PubMed. 3. 327–37. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Osinski Breakdown of academic impact, for papers by Gonzálo Emiliano Aranda-Abreu Breakdown of academic impact, for papers by André Bachy Breakdown of academic impact, for papers by Wolfram Gaida Breakdown of academic impact, for papers by James H. Allison Breakdown of academic impact, for papers by Jaroslav H. Boublik Breakdown of academic impact, for papers by Yoshiko Yamamoto Breakdown of academic impact, for papers by Guoming Zhang Breakdown of academic impact, for papers by David R. Luthin Breakdown of academic impact, for papers by Monika Schäfer
Rankless by CCL
2026